Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Iopamidol (SQ-13396) 是一种 benzenedicarboxamide 化合物。它具有放射性不透明介质、环境污染物和异种生物的作用。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 193 | 现货 | ||
50 mg | ¥ 289 | 现货 | ||
100 mg | ¥ 415 | 现货 | ||
500 mg | ¥ 1,120 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 164 | 现货 |
产品描述 | Iopamidol (SQ-13396) is a benzenedicarboxamide compound. It has a role as a radioopaque medium, an environmental contaminant and a xenobiotic. |
体外活性 | Iopamidol significantly decreases the rate of atrial contraction to a greater extent than either formulation of iodixanol. Iopamidol decreases papillary muscle force development more than the sodium formulation of iodixanol[3]. |
体内活性 | Iopamidol increases systolic blood pressure (SBP), mean arterial pressure (MAP), and peak left ventricular pressure (LVP). Iopamidol increases LVP and LV end diastolic pressure to a greater extent than the cationic formulation of iodixanol. Thus iopamidol affects cardiovascular parameters more than iodixanol[3]. |
细胞实验 | Chondrocytes are plated on 96 well plates at a density of 1 x 106 cells/cm2 . After overnight incubation in standard tissue culture conditions, contrast agents (including iopamidol) are introduced to wells in varying concentrations. Following 16 hour incubation with PBS and contrast agents, chondrocyte viability is assessed using the Live/Dead stain kit and quantified using the CellTiter-Glo Luminescent Cell Viability Assay. (Only for Reference) |
别名 | SQ-13396, Niopam, Iopamiron, Iopamiro, 碘帕醇, B-15000, Isovue |
分子量 | 777.09 |
分子式 | C17H22I3N3O8 |
CAS No. | 60166-93-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: < 1 mg/mL (insoluble or slightly soluble)
H2O: 92 mg/mL (118.4 mM)
DMSO: 93 mg/mL (119.7 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 1.2869 mL | 6.4343 mL | 12.8685 mL | 32.1713 mL |
5 mM | 0.2574 mL | 1.2869 mL | 2.5737 mL | 6.4343 mL | |
10 mM | 0.1287 mL | 0.6434 mL | 1.2869 mL | 3.2171 mL | |
20 mM | 0.0643 mL | 0.3217 mL | 0.6434 mL | 1.6086 mL | |
50 mM | 0.0257 mL | 0.1287 mL | 0.2574 mL | 0.6434 mL | |
100 mM | 0.0129 mL | 0.0643 mL | 0.1287 mL | 0.3217 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Iopamidol 60166-93-0 Others SQ-13396 B15000 contrast Niopam B 15000 Iopamiron diagnostic X-Ray agent inhibit SQ 13396 SQ13396 nonionic Iopamiro 碘帕醇 iodinated CEST Inhibitor B-15000 Isovue inhibitor